Logo image of ELK.OL

ELKEM ASA (ELK.OL) Stock Fundamental Analysis

Europe - OSL:ELK - NO0010816093 - Common Stock

27.35 NOK
+0.17 (+0.63%)
Last: 10/9/2025, 4:19:41 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ELK. ELK was compared to 71 industry peers in the Chemicals industry. ELK has only an average score on both its financial health and profitability. While showing a medium growth rate, ELK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ELK had negative earnings in the past year.
In the past year ELK had a positive cash flow from operations.
Each year in the past 5 years ELK has been profitable.
ELK had a positive operating cash flow in each of the past 5 years.
ELK.OL Yearly Net Income VS EBIT VS OCF VS FCFELK.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B 10B

1.2 Ratios

With a Return On Assets value of -0.92%, ELK is not doing good in the industry: 61.97% of the companies in the same industry are doing better.
ELK has a Return On Equity of -1.87%. This is in the lower half of the industry: ELK underperforms 63.38% of its industry peers.
The Return On Invested Capital of ELK (2.72%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ELK is in line with the industry average of 6.85%.
The 3 year average ROIC (8.73%) for ELK is well above the current ROIC(2.72%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.92%
ROE -1.87%
ROIC 2.72%
ROA(3y)6.39%
ROA(5y)6.2%
ROE(3y)11.85%
ROE(5y)12.17%
ROIC(3y)8.73%
ROIC(5y)8.61%
ELK.OL Yearly ROA, ROE, ROICELK.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ELK's Profit Margin has declined in the last couple of years.
ELK has a Operating Margin of 8.03%. This is in the better half of the industry: ELK outperforms 60.56% of its industry peers.
In the last couple of years the Operating Margin of ELK has grown nicely.
ELK's Gross Margin of 52.20% is amongst the best of the industry. ELK outperforms 80.28% of its industry peers.
ELK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.03%
PM (TTM) N/A
GM 52.2%
OM growth 3Y-7.33%
OM growth 5Y22.64%
PM growth 3Y-41.92%
PM growth 5Y-6.54%
GM growth 3Y0.8%
GM growth 5Y2.02%
ELK.OL Yearly Profit, Operating, Gross MarginsELK.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ELK is creating some value.
The number of shares outstanding for ELK remains at a similar level compared to 1 year ago.
The number of shares outstanding for ELK has been increased compared to 5 years ago.
ELK has a better debt/assets ratio than last year.
ELK.OL Yearly Shares OutstandingELK.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ELK.OL Yearly Total Debt VS Total AssetsELK.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

Based on the Altman-Z score of 1.76, we must say that ELK is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ELK (1.76) is worse than 66.20% of its industry peers.
ELK has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
ELK has a Debt to Equity ratio (0.48) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 1.76
ROIC/WACC0.37
WACC7.42%
ELK.OL Yearly LT Debt VS Equity VS FCFELK.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

A Current Ratio of 3.00 indicates that ELK has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.00, ELK belongs to the best of the industry, outperforming 87.32% of the companies in the same industry.
ELK has a Quick Ratio of 1.56. This is a normal value and indicates that ELK is financially healthy and should not expect problems in meeting its short term obligations.
ELK's Quick ratio of 1.56 is fine compared to the rest of the industry. ELK outperforms 74.65% of its industry peers.
Industry RankSector Rank
Current Ratio 3
Quick Ratio 1.56
ELK.OL Yearly Current Assets VS Current LiabilitesELK.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

ELK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.39%, which is quite good.
ELK shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.90% yearly.
ELK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.34%.
The Revenue has been decreasing by -4.35% on average over the past years.
EPS 1Y (TTM)11.39%
EPS 3Y-53.14%
EPS 5Y-11.9%
EPS Q2Q%-136.3%
Revenue 1Y (TTM)-35.34%
Revenue growth 3Y-18.65%
Revenue growth 5Y-4.35%
Sales Q2Q%-3.33%

3.2 Future

The Earnings Per Share is expected to grow by 35.84% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.38% on average over the next years.
EPS Next Y-182.81%
EPS Next 2Y27.27%
EPS Next 3Y35.84%
EPS Next 5YN/A
Revenue Next Year-6.28%
Revenue Next 2Y1.01%
Revenue Next 3Y2.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ELK.OL Yearly Revenue VS EstimatesELK.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B 40B
ELK.OL Yearly EPS VS EstimatesELK.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ELK. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 21.65, which indicates a rather expensive current valuation of ELK.
ELK's Price/Forward Earnings is on the same level as the industry average.
ELK is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 21.65
ELK.OL Price Earnings VS Forward Price EarningsELK.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

ELK's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ELK is cheaper than 83.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.97
ELK.OL Per share dataELK.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

ELK's earnings are expected to grow with 35.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.27%
EPS Next 3Y35.84%

1

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.09%, ELK has a reasonable but not impressive dividend return.
ELK's Dividend Yield is slightly below the industry average, which is at 3.05.
Compared to an average S&P500 Dividend Yield of 2.44, ELK's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.09%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y27.27%
EPS Next 3Y35.84%
ELK.OL Yearly Income VS Free CF VS DividendELK.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B

ELKEM ASA

OSL:ELK (10/9/2025, 4:19:41 PM)

27.35

+0.17 (+0.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-11 2025-07-11/bmo
Earnings (Next)10-23 2025-10-23
Inst Owners20.1%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap17.49B
Analysts78
Price Target28.89 (5.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.09%
Yearly Dividend6.02
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2034.13%
Min EPS beat(2)-2351.11%
Max EPS beat(2)-1717.16%
EPS beat(4)0
Avg EPS beat(4)-1057.71%
Min EPS beat(4)-2351.11%
Max EPS beat(4)-52.09%
EPS beat(8)1
Avg EPS beat(8)-1159.62%
EPS beat(12)3
Avg EPS beat(12)-775.14%
EPS beat(16)7
Avg EPS beat(16)-577.5%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-5.85%
Max Revenue beat(2)5.35%
Revenue beat(4)2
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-12.1%
Max Revenue beat(4)5.35%
Revenue beat(8)4
Avg Revenue beat(8)-2.65%
Revenue beat(12)6
Avg Revenue beat(12)-1.83%
Revenue beat(16)8
Avg Revenue beat(16)-0.79%
PT rev (1m)9.77%
PT rev (3m)20%
EPS NQ rev (1m)-83.33%
EPS NQ rev (3m)-138.5%
EPS NY rev (1m)-62.1%
EPS NY rev (3m)-152.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-4.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.65
P/S 0.85
P/FCF N/A
P/OCF 10.5
P/B 0.73
P/tB 0.75
EV/EBITDA 5.97
EPS(TTM)-0.7
EYN/A
EPS(NY)1.26
Fwd EY4.62%
FCF(TTM)-2
FCFYN/A
OCF(TTM)2.61
OCFY9.53%
SpS32.13
BVpS37.28
TBVpS36.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.92%
ROE -1.87%
ROCE 3.73%
ROIC 2.72%
ROICexc 2.91%
ROICexgc 2.95%
OM 8.03%
PM (TTM) N/A
GM 52.2%
FCFM N/A
ROA(3y)6.39%
ROA(5y)6.2%
ROE(3y)11.85%
ROE(5y)12.17%
ROIC(3y)8.73%
ROIC(5y)8.61%
ROICexc(3y)10.76%
ROICexc(5y)10.71%
ROICexgc(3y)11.49%
ROICexgc(5y)11.66%
ROCE(3y)12.41%
ROCE(5y)12.33%
ROICexcg growth 3Y-39.97%
ROICexcg growth 5Y-3.21%
ROICexc growth 3Y-38.01%
ROICexc growth 5Y-2.06%
OM growth 3Y-7.33%
OM growth 5Y22.64%
PM growth 3Y-41.92%
PM growth 5Y-6.54%
GM growth 3Y0.8%
GM growth 5Y2.02%
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA 2.54
Cap/Depr 104.17%
Cap/Sales 14.33%
Interest Coverage 1.99
Cash Conversion 37.2%
Profit Quality N/A
Current Ratio 3
Quick Ratio 1.56
Altman-Z 1.76
F-Score6
WACC7.42%
ROIC/WACC0.37
Cap/Depr(3y)178.1%
Cap/Depr(5y)168.55%
Cap/Sales(3y)17.35%
Cap/Sales(5y)14.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.39%
EPS 3Y-53.14%
EPS 5Y-11.9%
EPS Q2Q%-136.3%
EPS Next Y-182.81%
EPS Next 2Y27.27%
EPS Next 3Y35.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-35.34%
Revenue growth 3Y-18.65%
Revenue growth 5Y-4.35%
Sales Q2Q%-3.33%
Revenue Next Year-6.28%
Revenue Next 2Y1.01%
Revenue Next 3Y2.38%
Revenue Next 5YN/A
EBIT growth 1Y483.39%
EBIT growth 3Y-24.62%
EBIT growth 5Y17.3%
EBIT Next Year159.13%
EBIT Next 3Y56.1%
EBIT Next 5YN/A
FCF growth 1Y-213.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-72.6%
OCF growth 3Y-25.52%
OCF growth 5Y2%